EPOCH Epigenetics, Inc. — Form D
EPOCH Epigenetics, Inc. of BALTIMORE, MD, a company, filed a Form D exempt-offering notice with the SEC on 2025-06-16. The offering totals $3.0M, of which $73K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2025-06-16
- Form: D
- Accession: 0001231919-25-000075
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $73K
- Remaining: $2.9M
- Investors: 1
- Date of first sale: 2025-02-20
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-548984
Issuer
- Name: EPOCH Epigenetics, Inc.
- CIK: 0002068186
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2023
- Address: 4 N. MARTIN LUTHER KING JR. BLVD., BALTIMORE, MD, 21201
- Phone: (410) 801-6828
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Neil Hermansen | Director | Baltimore, MD |
| Joseph Swiader | Director | Baltimore, MD |
| Eric Van Gieson | Director | Baltimore, MD |
| Neil Hermansen | Executive Officer | Baltimore, MD |
| Joseph Swiader | Executive Officer | Baltimore, MD |
| Eric Van Gieson | Executive Officer | Baltimore, MD |
More